Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

All Approvals and Tentative Approvals
October 1962

This report includes approvals of NDAs, BLAs, ANDAs, and approved supplements to those applications, and tentative ANDA/NDA approvals during the selected month. This report does not include BLAs/NDAs and supplements to those applications approved by CBER.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on May 29, 2020.

Approval Date Drug Name Submission Active Ingredients Company Submission Classification * Submission Status
10/05/1962 DECA-DURABOLIN
NDA #013132
ORIG-1 NANDROLONE DECANOATE ASPEN GLOBAL INC Type 2 - New Active Ingredient Approval
10/11/1962 BICILLIN C-R
NDA #050138
SUPPL-38 PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE KING PHARMS LLC Labeling Approval
10/11/1962 BICILLIN C-R 900/300
NDA #050138
SUPPL-38 PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE KING PHARMS LLC Labeling Approval
10/12/1962 BICILLIN L-A
NDA #050141
SUPPL-59 PENICILLIN G BENZATHINE KING PHARMS LLC Manufacturing (CMC) Approval

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English